![]()
Key takeaways |
|---|
This article explores the current landscape of European startup funding, where world-class angel funding networks excel at launching new ventures but often hit a wall at the Series C stage. Learn why the continent struggles to match the scale-up firepower of global peers and carefully balancing early-stage diversity and massive growth capital is the best way to build lasting global champions. |
As the tech ecosystem starts looking toward VivaTech 2026, the mood is optimistic but the math isn’t. Europe has no shortage of world-class scientists or ambitious founders, yet, the “scale up gap” is still a stubborn reality. A European scale up typically raises about half as much as its peer in San Francisco, and the lack of high capital rounds continues to push Europe’s best talent toward non-European capital, or across the Atlantic entirely.
The EU hasn’t been idle. On one hand, we can see massive growth initiatives like the European Tech Champions Initiative targeting the scale-up gap. On the other, there’s a push to professionalize the early stage through programs like ESIL and important networks like Angels France. This focus is paying off; angel funding across the continent is growing steadily, fueled by an intricate network of incubators that prep founders for their first challenges. You can read more about these changing trends in our VivaTech Digest on the state of European tech.
This brings us to the fundamental question of capital allocation: If you had an extra euro to fix the European ecosystem today, would you give it to an Angel or a Series C investor?
The angels planting more seeds
Angels are the ecosystem’s R&D department. By funding first-time founders and backing experiments in underserved regions, they make sure the pipeline doesn’t dry up.
The strengths: Angel programs diversity the ecosystem. They’re often the first to back female founders or entrepreneurs outside the major hubs of London, Paris, or Berlin. Without a wide net, we miss out on the next generation of breakthroughs.
The weaknesses: A fragmented angel market often lacks the professional muscle to prep companies for the global stage. A thousand flowers blooming is great, but it doesn’t mean as much if they don’t have the soil to grow tall.
Can Series C help raise the forest?
Series C capital is the firepower investment stage. This is where Europe has historically struggled. Currently, Series C investments invest up to 3x less per capita in late-stage VC than the US.
The strengths: Growth capital prevents brain drain. When we can write €50M+ checks into deep tech, artificial intelligence, and climate tech at home, we can keep our champions European. It allows companies to focus on market dominance rather than survival.
The weaknesses: You can’t brute force a champion. Without a high quality early-stage pipeline and sensible entry valuations, growth funds end up chasing too few deals, driving up prices for companies that aren’t actually global-champion ready.
If you were an investor, where would you plant €1B?
The seed investor: Favors the angel route to make sure a broad, diverse pipeline of early startups exists. They’d argue that more swings at the ball today would mean more home runs later.
The growth lead: Prioritizes Series C investment to get the finishing capital that Europe lacks. They would prefer shifting the focus from just starting companies to investing the large cash amount needed to build global winners.
The deep tech specialist: Would be on board for Series C firepower. In capital-intensive sectors like fusion or quantum, small angel checks would just be a drop in the ocean compared to the heavy investment that’s actually needed to move the needle.
The verdict: fixing the weakest rung
A healthy ecosystem is a ladder. If one rung is missing, the climb gets harder. However, in the big 26, the data points to a specific bottleneck.
While Europe has successfully increased the number of startups, it’s still losing the sovereignty battle at the finish line. The weakest rung in 2026 isn’t the ability to start a company; it’s the ability to stay the course during the most expensive years of growth.
Our take: For VCs and LPs walking the halls of VivaTech, the priority should be Series C firepower. We’ve mastered the art of the startup with countless great ideas that have the possibility to change the world. Now, Europe must master the art of the scale-up. Unless the European ecosystem wants to continue being the laboratory for the rest of the world, the funding gap needs to close.
The next euro shouldn’t just plant a seed, it should protect the harvest.
Are you looking to grow your sprout or maybe water one? VivaTech 2026 is the perfect place to do both; get your pass and get your hands dirty this June.
FAQs |
|---|
What is an angel investor?An angel investor is an individual who provides early-stage capital to startups, usually in exchange for equity, during the seed phase when risks are highest. |
What is Series C investing?Series C is a big round of funding for companies that are already semi-successful and looking to scale quickly, expand into new markets, or acquire other businesses. |
What is the scale up gap?The scale-up gap refers to the shortage of late-stage capital in Europe compared to the US, which often forces growing companies to look overseas for funding. |


